Found 13 matching trials
DZD9008 PK Study in Hepatic Impairment Subjects
PHASE1This study will investigate the pharmacokinetics, safety, and tolerability ...
Location
Orlando Clinical Research Center
Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)
PHASE1This study will treat patients with advanced NSCLC with EGFR or HER2 mutati...
Status
Active Not Recruiting
Location
University of California, San Diego (UCSD) - Moores Cancer Center
Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6)
PHASE2This is a Phase II, single-arm, multi-center clinical study to evaluate the...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations (WU-KONG21)
PHASE2DZD9008 in combination with AZD4205 for the treatment of patients with adva...
Location
Guangdong Provincial People'S Hospital
Assessing an Oral Bruton Tyrosine Kinase Inhibitor, DZD9008 in Patients Who Have Non-Hodgkin B-cell Lymphoma (WU-KONG3)
PHASE1This study will treat patients with non-Hodgkin B-cell lymphoma who have re...
Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)
PHASE3This is a phase 3, open-label, randomized, multi-center study assessing the...
Status
Active Not Recruiting
Location
OPN Healthcare, Inc.
DZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29)
PHASE2This study tests a combination therapy (i.e., DZD9008 plus bevacizumab) in ...
Location
Shanghai Chest Hospital
Drug-drug Interactions Between DZD9008 and Itraconazole/Carbamazepine
PHASE1This is a Phase 1, single-center, nonrandomized, open-label, 2-part, fixed-...
Location
Pharmaceutical Research Associates, Inc.
Assessing the Safety, Tolerability and Pharmacokinetics(PK) of DZD9008 and the Effect of Low-fat Meal on PK of DZD9008 in Healthy Adult Participants
PHASE1This is a Phase 1, randomised, double-blind, placebo-controlled, single asc...
Location
PRA Health Sciences
Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15)
NAThis study is a single center cohort study to access the anti-tumor efficac...
Location
Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital